Literature DB >> 15876788

Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK.

Satoshi Takagi1, Takanori Kitamura, Yoshinao Hosaka, Tomohiro Ohsaki, Darko Bosnakovski, Tsuyoshi Kadosawa, Masahiro Okumura, Toru Fujinaga.   

Abstract

The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene is one of the endogenous matrix metalloproteinase (MMP) inhibitors. It was reported that decreased RECK expression closely correlated with tumor malignancy. We determined the cDNA sequence of the canine RECK gene. The cDNA sequence and deduced amino acid of canine RECK were 2,913 bases and 971 residues, respectively. The predicted amino acid sequence of the protein showed 95.5% and 91.9% homology with human and mouse RECK, respectively. RECK mRNA expression was analyzed in various canine tissues and tumor cell lines by quantitative RT-PCR. The highest RECK expression was detected in lung and testis. In comparison with the tissues, a remarkably low expression level was detected in tumor cell lines. In addition, the RECK gene was transfected in the canine transitional cell carcinoma, and its influence on cell proliferation, migration, and invasion was analyzed. The transfected RECK gene suppressed only canine tumor invasion. These results showed that RECK might play an important role in tumor malignancy in dogs as well as in other mammalians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876788     DOI: 10.1292/jvms.67.385

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  5 in total

1.  Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Authors:  Xuan Zhang; Caitlin Healy; Warren B Nothnick
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).

Authors:  Daizo Yoshida; Ryutaro Nomura; Akira Teramoto
Journal:  J Neurooncol       Date:  2008-05-21       Impact factor: 4.130

3.  Matrix metalloproteinases and their inhibitors in canine mammary tumors.

Authors:  Luca Aresu; Mery Giantin; Emanuela Morello; Marta Vascellari; Massimo Castagnaro; Rosa Lopparelli; Vanessa Zancanella; Anna Granato; Spiridione Garbisa; Arianna Aricò; Alice Bradaschia; Franco Mutinelli; Mauro Dacasto
Journal:  BMC Vet Res       Date:  2011-07-04       Impact factor: 2.741

4.  Reference gene validation for gene expression normalization in canine osteosarcoma: a geNorm algorithm approach.

Authors:  Gayathri Thevi Selvarajah; Floor A S Bonestroo; Elpetra P M Timmermans Sprang; Jolle Kirpensteijn; Jan A Mol
Journal:  BMC Vet Res       Date:  2017-11-25       Impact factor: 2.741

5.  Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells.

Authors:  Yusuke Murase; Kenji Hosoya; Takachika Sato; Sangho Kim; Masahiro Okumura
Journal:  Oncol Rep       Date:  2022-01-28       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.